Sequella, Inc.

Rockville, MD 20850

SBIR Award Summary

Total Number of Awards 28
Total Value of Awards $10.5MM
First Award Date 09/01/98
Most Recent Award Date 03/01/13

Key Personnel

Last Name Name Awards Contact
Nacy Carol A. Nacy 7
Einck Leo Einck 7
Nikonenko Boris V Nikonenko 1
Protopopova Marina N Protopopova 4
Dijkstra Jan Dijkstra 1
Reddy Venkata M Reddy 7
Mulvey Matthew Charles Mulvey 1

28 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-10-123
Budget: 03/01/13 - 02/28/14

DESCRIPTION (provided by applicant): World Health Organization (WHO) declared tuberculosis (TB) a global health emergency;a distinction never accorded another disease. Two billion people are infected with Mycobacterium tuberculosis (Mtb) worldwide, leading to over 9 million new TB cases each year and nearly 2 million deaths. A considerable obsta...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-10-123
Budget: 03/01/12 - 02/28/13

DESCRIPTION (provided by applicant): World Health Organization (WHO) declared tuberculosis (TB) a global health emergency;a distinction never accorded another disease. Two billion people are infected with Mycobacterium tuberculosis (Mtb) worldwide, leading to over 9 million new TB cases each year and nearly 2 million deaths. A considerable obsta...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-10-124
Budget: 03/01/12 - 02/28/13

DESCRIPTION (provided by applicant): Tuberculosis (TB) has a massive impact on global health. The World Health Organization estimates that one- third of all people worldwide harbor latent TB infections, with sixteen million cases of active disease and nearly two million deaths caused by Mycobacterium tuberculosis (MTB) each year. TB infections a...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-10-124
Budget: 03/01/11 - 02/29/12

DESCRIPTION (provided by applicant): Tuberculosis (TB) has a massive impact on global health. The World Health Organization estimates that one- third of all people worldwide harbor latent TB infections, with sixteen million cases of active disease and nearly two million deaths caused by Mycobacterium tuberculosis (MTB) each year. TB infections a...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-09-115
Budget: 02/01/11 - 01/31/12
PI: Leo Einck

DESCRIPTION (provided by applicant): SQ109 is a small molecule, orally active drug and is a new drug candidate in clinical development for the treatment of all forms of tuberculosis (TB), including multi-drug resistant (MDR) and extreme drug resistant (XDR) TB. SQ109 has a unique pharmacological profile, and is safe and well-tolerated in animals...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-134
Budget: 09/01/10 - 08/31/12

DESCRIPTION (provided by applicant): Mycobacterium avium complex (MAC) and M. abscessus (MAB) are the two most common nontuberculous mycobacteria (NTM) that cause human disease, and the incidence of NTM infections has been increasing worldwide. Both the organisms are generally resistant to standard antimybacterial drugs and other antibiotics. He...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-134
Budget: 09/01/10 - 08/31/12

DESCRIPTION (provided by applicant): Physicians treating tuberculosis (TB) today are in desperate need of new, efficient, and effective antibiotics to improve both time of treatment and durability of cure in multi-drug resistant (MDR) as well as uncomplicated TB. In the completed Phase 1 grant (Final Report below), we evaluated an exciting new d...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-09-115
Budget: 02/01/10 - 01/31/11
PI: Leo Einck

DESCRIPTION (provided by applicant): SQ109 is a small molecule, orally active drug and is a new drug candidate in clinical development for the treatment of all forms of tuberculosis (TB), including multi-drug resistant (MDR) and extreme drug resistant (XDR) TB. SQ109 has a unique pharmacological profile, and is safe and well-tolerated in animals...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-134
Budget: 09/01/09 - 08/31/10

DESCRIPTION (provided by applicant): Physicians treating tuberculosis (TB) today are in desperate need of new, efficient, and effective antibiotics to improve both time of treatment and durability of cure in multi-drug resistant (MDR) as well as uncomplicated TB. In the completed Phase 1 grant (Final Report below), we evaluated an exciting new d...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-06-134
Budget: 09/01/09 - 08/31/10

DESCRIPTION (provided by applicant): Mycobacterium avium complex (MAC) and M. abscessus (MAB) are the two most common nontuberculous mycobacteria (NTM) that cause human disease, and the incidence of NTM infections has been increasing worldwide. Both the organisms are generally resistant to standard antimybacterial drugs and other antibiotics. He...

Load More